Covestor LTD Vanda Pharmaceuticals Inc. Transaction History

Covestor LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.47 - $4.61 $79 - $106	-23 Reduced 7.44%	286 $1,000
Q4 2023 Feb 09, 2024	BUY	$3.38 - $4.58 $327 - $444	97 Added 45.75%	309 $1,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $162 - $249	38 Added 21.84%	212 $1,000
Q2 2023 Aug 11, 2023	SELL	$5.9 - $6.95 $2,165 - $2,550	-367 Reduced 67.84%	174 $1,000
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $1,699 - $2,197	275 Added 103.38%	541 $4,000
Q4 2022 Feb 13, 2023	SELL	$6.87 - $10.96 $89 - $142	-13 Reduced 4.66%	266 $1,000
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $66 - $82	-7 Reduced 2.45%	279 $3,000
Q2 2022 Aug 10, 2022	SELL	$9.31 - $11.84 $130 - $165	-14 Reduced 4.67%	286 $3,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $2,428 - $3,707	224 Added 294.74%	300 $3,000
Q4 2021 Feb 10, 2022	BUY	$15.69 - $21.14 $1,192 - $1,606	76 New	76 $1,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.